Biomolecule Detection with Particle Enrichment and Internal Standards

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting and quantifying biomolecules suffer from misclassification, reduced signal-to-noise ratio, interference from high abundance biomolecules, and lack of real-time quality control during nanoparticle enrichment, leading to inaccurate and unreliable disease detection.

Innovation Solution

Incorporating internal standards and particles to adsorb biomolecules, allowing for real-time quality control and normalization of measurements, and using multiple data sets with classifiers to improve detection and classification of biomolecules, particularly for early-stage disease detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If particles are used to adsorb biomolecules for enrichment, then the detection sensitivity is improved, but the measurement accuracy deteriorates due to interference from high abundance biomolecules

Engineering Contradiction:
Improvedetection sensitivityVSAvoidmeasurement accuracy
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

Labeled reference biomolecules are introduced as intermediary substances that compete with endogenous biomolecules for adsorption sites on particles. These reference biomolecules serve as mediators to establish a known relationship between adsorption signal and actual biomolecule concentration, enabling accurate quantification despite the presence of high abundance interfering biomolecules.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The method changes the parameter of biomolecule concentration by adding known amounts of labeled reference biomolecules to the sample. This parameter change allows the system to calibrate the adsorption process and establish a reference curve that accounts for interference effects, thereby improving measurement accuracy while maintaining detection sensitivity.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If internal standards are added to normalize measurements, then the quantitative accuracy is improved, but the device complexity increases

Engineering Contradiction:
Improvequantitative accuracyVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The labeled reference biomolecules serve multiple functions simultaneously: they act as internal standards for normalization, compete for adsorption sites to establish calibration curves, and provide quality control metrics. This multi-functionality reduces the need for separate control mechanisms, thereby limiting the increase in device complexity while achieving improved quantitative accuracy.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If multiple data sets with classifiers are used to improve disease detection accuracy, then the detection reliability is improved, but the loss of time increases due to processing multiple measurements

Engineering Contradiction:
Improvedisease detection accuracyVSAvoidprocessing time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The method performs preliminary classification of biomolecule measurements into distinct data sets before final disease detection analysis. By pre-organizing the data and applying classifiers in advance, the system reduces the computational burden during final interpretation, thereby limiting time loss while maintaining improved detection reliability through multiple data sets.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enhances the accuracy and reproducibility of biomolecule measurement, enabling non-invasive early-stage disease detection and classification, reducing uncertainty and improving the reliability of disease identification.

Implementation Method 1

contacting a biological sample of a subject with particles, thereby adsorbing endogenous biomolecules of the biological sample to the particles

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentEP4711762A1Enhanced detection and quantitation of biomolecules
Publication Date: 2026.03.18 PROGNOMIQ INC
  • EP4711762A1 patent drawingFigure 1
  • EP4711762A1 patent drawingFigure 2
  • EP4711762A1 patent drawingFigure 3A

AI summary

Described herein are methods for screening for a disease state. The method may include obtaining multiple data sets, and identifying the disease state based on a combination of the data sets. The data sets may include biomolecule measurements obtained by multiple methods, such as through the use of particles and reference biomolecules.